Skip to main content
Table of Contents
Print

 Anxiety Drugs? 

Author: Julia Sutton, MSc | Reviewed by: Dr. Clarissa Morton, PharmD

Patients using cannabis alongside prescription of anxiety  medications should be aware of potential cannabis drug interactions with SSRIs. Combining treatments without oversight may affect drug metabolism, efficacy, and safety. Evaluating medication interactions, benzodiazepine safety, and the polypharmacy of cannabis helps clinicians provide informed guidance for co-use. 

Understanding Cannabis and Anxiety Medications 

Recognising cannabis drug interactions with SSRIs ensures safe and effective treatment planning for anxiety patients. 

Medication Interactions 

Cannabis can influence liver enzymes responsible for metabolising SSRIs and other drugs, raising the risk of altered blood levels and unexpected side effects. Careful monitoring is advised to minimise medication interactions. 

Benzodiazepine Safety 

Using cannabis alongside benzodiazepines requires attention to benzodiazepine safety, as combined sedative effects may increase drowsiness, impaired coordination, or respiratory concerns in sensitive individuals. 

Polypharmacy of Cannabis 

Polypharmacy of cannabis, using multiple cannabinoid products simultaneously can further complicate interactions with SSRIs or benzodiazepines, making dosage adjustments and professional oversight critical. 

Clinical Recommendations 

Clinicians should assess patient history, current medications, and symptom severity when evaluating cannabis drug interactions with SSRIs. Adjusting cannabis type, dose, and timing can mitigate risks while maintaining therapeutic benefits. 

Understanding cannabis drug interactions with SSRIs, including medication interactions, benzodiazepine safety, and polypharmacy of cannabis, helps ensure safe co-use in anxiety treatment. Professional guidance and regular monitoring remain essential for patient safety and optimal outcomes. 

If you’re exploring cannabis treatment options for anxiety disorders, visit providers like LeafEase for personalised consultations and guidance tailored to your needs. 

For a deeper dive into the science, diagnosis, and full treatment landscape, read our complete guide to Medical Cannabis and anxiety disorders. 

Julia Sutton, MSc
Author

Julia Sutton is a clinical psychologist with a Master’s in Clinical Psychology and experience providing psychological assessment and therapy to adolescents and adults. Skilled in CBT, client-centered therapy, and evidence-based interventions, she has worked with conditions including depression, anxiety, bipolar disorder, and conversion disorder. She also has experience in child psychology, conducting psycho-educational evaluations and developing tailored treatment plans to improve learning and well-being.

All qualifications and professional experience stated above are authentic and verified by our editorial team. However, pseudonym and image likeness are used to protect the author's privacy. 

Dr. Clarissa Morton, PharmD
Reviewer

Dr. Clarissa Morton is a licensed pharmacist with a Doctor of Pharmacy degree and experience across hospital, community, and industrial pharmacy. She has worked in emergency, outpatient, and inpatient pharmacy settings, providing patient counseling, dispensing medications, and ensuring regulatory compliance. Alongside her pharmacy expertise, she has worked as a Support Plan & Risk Assessment (SPRA) officer and in medical coding, applying knowledge of medical terminology, EMIS, and SystmOne software to deliver accurate, compliant healthcare documentation. Her skills span medication safety, regulatory standards, healthcare data management, and statistical reporting.

All qualifications and professional experience stated above are authentic and verified by our editorial team. However, pseudonym and image likeness are used to protect the reviewers's privacy. 

Categories